Durational Therapeutic Dose of Fansidar: A Functional Index in Its Antidiabetic Properties ()
ABSTRACT
Effects of fansidar in
alloxan-induced diabetes were investigated in thirty (30) male and female albino rats for 28 days. The
results showed a steady weekly decrease in blood glucose concentration in
induced diabetic rats after fansidar treatment. In week 1, i.e. 7 days, there was significant difference in the blood glucose
levels between the control and diabetic rats (P < 0.05) i.e. high glucose concentration, same in week II i.e. 14 days. However, in day 21 i.e. week
III there was a significant reduction in the blood glucose concentration
compared with control P < 0.05. The same results were obtained in week IV i.e. in 28 days treatment. The result
has shown that fansidar has antidiabetic potentials on long term durational
administration.
Share and Cite:
Jimmy, E. (2019) Durational Therapeutic Dose of Fansidar: A Functional Index in Its Antidiabetic Properties.
Journal of Biosciences and Medicines,
7, 23-28. doi:
10.4236/jbm.2019.71003.
Cited by
No relevant information.